Long-term effects of interleukin-2 on CD4 cell counts in human immunodeficiency virus-infected patients.
Ramachandran
R V
RV
Katzenstein
D
D
Merigan
T C
TC
D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D005500:Follow-Up Studies; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011092:Polyethylene Glycols; D012189:Retrospective Studies; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use
D007376:Interleukin-2; C067245:interleukin-2, polyethylene glycol-modified; D011092:Polyethylene Glycols; D015215:Zidovudine